Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Crystal structure of an actinidin-E-64 complex.

K I Varughese1, Y Su, D Cromwell

  • 1Department of Biology, University of California, San Diego, La Jolla 92093-0317.

Biochemistry
|June 9, 1992
PubMed
Summary

The crystal structure reveals how E-64, a cysteine protease inhibitor, covalently binds to actinidin. This precise structural data confirms E-64 targets S subsites, aiding drug design.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The National Pancreatic Cancer Audit: Reducing Variation in Clinical Practice.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

Reducing Variation in Palliative Treatment for Oesophago-Gastric Cancer: Insights from the National Oesophago-Gastric Cancer Audit.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

The National Audit of Metastatic Breast Cancer (NAoMe): Sharing Key Findings and Recommendations From the 2025 State of the Nation Report.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

The National Lung Cancer Audit: The Impact of COVID-19.

Clinical oncology (Royal College of Radiologists (Great Britain))·2022
Same author

Effectiveness of emergency surgery for five common acute conditions: an instrumental variable analysis of a national routine database.

Anaesthesia·2022
Same author

Per-Cutaneous Trans-splenic Vein Thrombolysis of Acute Major Portal Vein Thrombosis in Post-Liver Transplant Recipient: A Unique Experience.

International journal of organ transplantation medicine·2022

Area of Science:

  • Biochemistry
  • Structural Biology
  • Enzymology

Background:

  • Cysteine proteases are crucial enzymes involved in various biological processes.
  • E-64 is a well-established irreversible inhibitor of cysteine proteases.
  • Understanding the precise binding mechanism of E-64 is vital for developing targeted therapies.

Purpose of the Study:

  • To determine the high-resolution crystal structure of the actinidin-E-64 complex.
  • To elucidate the detailed molecular interactions between E-64 and actinidin.
  • To confirm the binding site of E-64 within the protease active site.

Main Methods:

  • X-ray crystallography was used to determine the structure of the actinidin-E-64 complex at 1.86-A resolution.
  • Difference Fourier method and refinement were employed to analyze the electron density map.
  • Comparison with the papain-E-64 complex structure was performed.

Main Results:

  • The C2 atom of E-64's epoxide ring is covalently bonded to the active-site cysteine 25 (Cys25) of actinidin.
  • The carboxyl group of E-64 forms hydrogen bonds, positioning the inhibitor for attack.
  • The amino-4-guanidinobutane group shows a different orientation compared to the papain complex.
  • Binding was confirmed to occur at the S subsites, not S' subsites.

Conclusions:

  • The study provides precise geometrical details of E-64 binding to actinidin, surpassing previous papain-E-64 complex data.
  • The findings reinforce the covalent mechanism of E-64 inhibition via nucleophilic attack by Cys25.
  • The results confirm E-64's specificity for S subsites, offering valuable insights for designing new cysteine protease inhibitors.

Related Experiment Videos